期刊文献+

子宫上皮细胞稳定性FH检测在诊断宫颈癌及癌前病变中的临床意义 被引量:14

The Clinical Significance of Uterine Epithelial Cells Stability FH Test in Cervical Cancer and Precancerous Lesions
原文传递
导出
摘要 [目的]评价子宫上皮细胞稳定性FH检测技术在诊断宫颈癌及癌前病变中的临床意义。[方法]对经病理学诊断的宫颈上皮内瘤变(CIN)、宫颈癌、宫颈良性病变及宫颈正常的女性共540例,进行子宫上皮细胞稳定性FH检测和宫颈细胞学(TCT)检查,比较两种检测方法的敏感度及特异性。[结果]子宫上皮细胞稳定性FH检测诊断CIN2-3、宫颈癌的敏感度分别为76.3%(95%CI:70.3%-82.2%)、94.4%(95%CI:89.1%-99.7%),与TCT检测的敏感度差异无统计学意义。子宫上皮细胞稳定性FH检测诊断宫颈病变的特异性为64.4%(95%CI:58.7%-70.2%),低于TCT检测的特异性。[结论 ]子宫上皮细胞稳定性FH检测对诊断宫颈病变具有较高的敏感度,且具有快速、简便、经济的特点,适用于偏远贫困地区女性的宫颈癌筛查。 [Purpose] To investigate the clinical significance of uterine epithelial cells stability FH test in cervical cancer and precancerous lesions. [Methods] A total of 540 women pathologically diagnosed with cervical intraepithelial neoplasia(CIN),cervical cancer,cervical benign lesions and normal cervix were detected by uterine epithelial cells stability FH test and Thin-prep cytology test(TCT). The sensitivity and specificity of Thin-prep cytology test(TCT) and uterine epithelial cells stability FH test for cervical lesions were compared. [Results] The sensitivity of uterine epithelial cells stability FH test in detecting CIN,cervical cancer were 76.3%(95% CI:70.3% -82.2%),94.4%(95% CI:89.1% -99.7%),respectively,which was no significant difference compared with TCT test. The specificity of uterine epithelial cells stability FH test in detecting cervical lesions was 64.4%(95%CI:58.7%-70.2%),which was lower than that in TCT test. [Conclusion] Uterine epithelial cells stability FH test,characterized as is rapid,simple and economical,has a high sensitivity in detecting cervical lesions,and can be used for cervical cancer screening,especially for women in remote poverty-stricken areas.
出处 《中国肿瘤》 CAS 2015年第10期881-883,共3页 China Cancer
基金 山东省科技发展计划项目(2014GGH218029) 山东大学齐鲁医院科研基金资助项目(2015QLMS48)
关键词 子宫上皮细胞稳定性FH检测 宫颈癌 游离亚铁血红素 敏感度 特异性 uterine epithelial cells stability FH test cervical cancer cervical precancerous lesions free heme sensitivity specificity
  • 相关文献

参考文献11

  • 1Huh WK,Ault KA,Chelmow D,et al.Use of primary high-risk human papillomavirus testing for cervical cancer screening:interim clinical guidance[J].Gynecol Oncol,2015,136(2):178-182.
  • 2Zong U,Zhang YZ,Yang XS,et al.Evaluation of several screening approaches for detection of cervical lesions in rural shandong,china[J].Asian Pac J Cancer Prev,2015,16(5):1907-1912.
  • 3Wright TC,Stoler MH,Behrens CM,et al.Primary cervical cancer screening with human papillomavirus:end of study results from the ATHENA study using HPV as the first-line screening test[J].Gynecol Oncol,2015,136(2):189-197.
  • 4Kuhl T,Imhof D.Regulatory Fe (11/111)heme:the recon- struction of a molecule's biography[J].Chembiochem,2014,15(14):2024-2035.
  • 5Sassa S.Why heme needs to be degraded to iron,biliverdin K alpha,and carbon monoxide?[J].Antioxid Redox Signal,2004,6(5):819-824.
  • 6Shen J,Sheng X,Chang Z,et al.Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization,stability,and function[J].Cell Rep,2014,7(1):180-193.
  • 7Hooda J,Cadinu D,Alam MM,et al.Enhanced heme function and mitochondrial respiration promote the pro- gression of lung cancer cells[J].PLoS One,2013,8(5):e63402.
  • 8Bernard X,Robinson P,Nomine Y,et al.Proteasomal degradation of p53 by human papillomavirus E6 oncopro- tein relies on the structural integrity of p53 core domain[J].PLoS One,2011,6(10):e25981.
  • 9Qiao Y.Perspective of cervical cancer prevention and con- trol in developing countries and areas[J].Chin J Cancer,2010,29(l);l-3.
  • 10Shi JFjCanfell K,Lew JB,et al.The burden of cervical cancer in China:synthesis of the evidence[J].Int J Can- cer,2012,130(3):641-652:.

同被引文献96

引证文献14

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部